Promising Developments and Strong Financial Outlook Justify Buy Rating for Rocket Pharmaceuticals
Analyst Whitney Ijem from Canaccord Genuity maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) and increased the ...
Business Insider3h
Rocket Pharmaceuticals: Strategic Advancements and Strong Financial Position Justify Buy Rating
Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The firm’s clinical program is a LVV-based gene therapy for ...
LinkedIn has seen an increase in users who list preferred pronouns despite 'woke' backlash
LinkedIn has seen a 29% increase this year in users who list their preferred pronouns. Experts say it's becoming a part of ...